CT and Contrast-Induced Nephrophathy (CIN)

Size: px
Start display at page:

Download "CT and Contrast-Induced Nephrophathy (CIN)"

Transcription

1 CT and Contrast-Induced Nephrophathy (CIN) Philipp A Kaufmann, MD Professor and Director of Cardiac Imaging University Hospital Zurich, Switzerland DISCLOSURE: Institutional Research contract with GE

2 CIN controversy CIN is a subgruop of acute kidney injury (AKIN) Almost everything about CIN is subject to debate, including its definition methods for measuring the condition causative agents the mechanism for damage the best means of prevention, and its true effect on mortality rates

3 CIN: definition Common definition: Serum creatinine increase 25% and/or 44 μmol/l = 0.5 mg/dl or more from baseline after contrast material exposure In different trials only parts of the definition were used The time point serum creatinin increase measurement was not standardized

4 CIN background Contrast-induced nephropathy (CIN) was first recognized more than 50 years ago. Bartels E, Brun GC, Gammeltof A, Gjorup LA. Acute anuria following intravenous pyelography in a patient with myelomatosis. Acta Med Scand. 1954;150: Contrast media have changed over time to become increasingly safe and well tolerated, but the indications for use of contrast media have greatly expanded. There are now more than 25,000 CT scanners worldwide.

5 CIN background The number of CT examinations performed annually has increased as improvements in technology have created new indications for CT and CT angiography. In the United States alone, 50 million CT procedures are performed annually, and approximately 50% of CT examinations use contrast. Cardiac catheterization and percutaneous coronary intervention (PCI) increased 390% between 1979 and 2002 (further increase occuring now)

6 CIN impact on outcome From AM et al. Mayo Clin Proc. 2008;83(10):

7 CIN impact on outcome Twofold-to-fivefold increase in mortality while patients are in the hospital, mostly related to an increase in adverse cardiac events. Hospital resource consumption is increased. Hospital lengths of stay increase by 5-10 days. Use of dialysis facilities increases 10% to 15%. Long-term mortality (at 1 year) also increases threefold. If dialysis required: In-hosp mortality up to 35%.

8 CIN is a predictable event Occurring immediately after exposure to contrast media (both iodinated contrast and gadolinium compounds) in vulnerable individuals. Its incidence is 10% to 50% in susceptible individuals receiving cardiac angiography, rising in parallel with the baseline serum creatinine level. The incidence for CT studies is less clear.

9 CIN facts But the minority is a CT coronary angiography! Nash K et al. Am J Kidney Dis. 2002;39:

10 CIN in cath pts (n=1 196)

11 CIN risk factors D. mellitus+renal failure, oral antidiabetics (metformin) Renal disease or solitary kidney disease Aged 70 years or older Sepsis or acute hypotension Cardiovascular disease Organ transplant Nephrotoxic drugs (e.g. nonsteroidal anti-inflammatory drugs, chemotherapy) Human immunodeficiency syndrome or acquired immunodeficiency syndrome

12 CIN: how big is the problem? Risk of CIN lower than 2% in general population. Highest for for patients who have impaired renal function in combination with diabetes. The estimated GFR, using serum creatinine measurements, is thought to be more accurate than serum creatinine level alone for measuring risk for CIN. GFR 60 to 30 ml/min: 10% to 20% risk of CIN GFR <30 ml/min: 40% to 50% risk of CIN

13 From cath to CT: differential impact Intra-arterial CM application may be more toxic. Multiple bolus injection of CM in the cath as opposed to one bolus in CT coronary angiography may have molre adverse impact. Patients undergoing CT coronary angiography are younger, have much less concomitant disease.

14 CIN: Impact of different CM

15 Pugliese F, RAD Magazine 2008

16 Pugliese F, RAD Magazine 2008

17 Differences between 5 PCI studies Aspelin et al. N Engl J Med. 2003; Jo et al. J Am Coll Cardiol. 2006; Solomon RJ et al. Circ. 2007; Nie et al. Catheter Cardiovasc Int. 2008; Wessely R et al. ACC 2008 abstract.

18 CIN- Incidence in 5 PCI studies Aspelin et al. N Engl J Med. 2003; Jo et al. J Am Coll Cardiol. 2006; Solomon RJ et al. Circ. 2007; Nie et al. Catheter Cardiovasc Int. 2008; Wessely R et al. ACC 2008 abstract.

19 CIN in CCTA

20 CIN and coronary CT angiography (CCTA) Most of the CIN risk factors are rare in CCTA, as mainly used for CAD rule out or coron. anomalies in younger patients decreased GFR unlikely nephrotoxic drugs rare iv is less nephrotoxic than ic/ia where bolus reaches kidney almost undiluted CM bolus much smaller than in cath

21 CM bolus in CT much lower than in cath Pazhenkottil et al. In J Card Imag 2010;26:

22 1997

23 Procedure related CIN Cardiac cath CT overall Periph. cath ERCP Pulmon. angio Cholangiography Renal angiography For CT angio only few individual cases have been observed Nash K et al. Am J Kidney Dis. 2002;39:

24 CIN: Strategies of prevention Fischman & Reddan. Acta Radiol 2008

25 Fischman & Reddan. Acta Radiol 2008

26

27 If you image, image gently! Non-invasively Low CM Low radiation (1-2m Sv) Be diagnostic! Be evidence-based:

28

29 Husmann et al. Eur Heart J 2008;29: msv

30 Kaufmann, Knuuti EHJ 2010

31 A L A R A!

32

33

34 If you image, image gently! Non-invasively Low CM Low radiation (1-2m Sv) Be diagnostic! Be evidence-based: Choose low-dose CT-angiography!

Safety of contrast agents CT / MR / Echo

Safety of contrast agents CT / MR / Echo International Conference on Integrated Medical Imaging in Cardiovascular Diseases (IMIC 2013, IAEA) Safety of contrast agents CT / MR / Echo Philipp A Kaufmann, MD Professor and Director of Cardiac Imaging

More information

16/05/2018 NEFROPATIA DA MEZZO DI CONTRASTO: ANCORA UNA VECCHIA NEMICA?

16/05/2018 NEFROPATIA DA MEZZO DI CONTRASTO: ANCORA UNA VECCHIA NEMICA? 16/05/2018 NEFROPATIA DA MEZZO DI CONTRASTO: ANCORA UNA VECCHIA NEMICA? Dott. Andrea Boccatonda Università degli Studi G. d Annunzio Chieti Chi di voi non ha mai discusso con un radiologo per eseguire

More information

Minimizing the Renal Toxicity of Iodinated Contrast

Minimizing the Renal Toxicity of Iodinated Contrast Minimizing the Renal Toxicity of Iodinated Contrast Peter A. McCullough, MD, MPH, FACC, FACP, FAHA, FCCP Chief Academic and Scientific Officer St. John Providence Health System Detroit, MI USA Outline

More information

Contrast-Induced Nephropathy: Evidenced Based Prevention

Contrast-Induced Nephropathy: Evidenced Based Prevention Contrast-Induced Nephropathy: Evidenced Based Prevention Michael J Cowley, MD, FSCAI Nothing to disclose Contrast-Induced Nephropathy (CIN) Definitions New onset or worsening of renal function after contrast

More information

Optimal Use of Iodinated Contrast Media In Oncology Patients. Focus on CI-AKI & cancer patient management

Optimal Use of Iodinated Contrast Media In Oncology Patients. Focus on CI-AKI & cancer patient management Optimal Use of Iodinated Contrast Media In Oncology Patients Focus on CI-AKI & cancer patient management Dr. Saritha Nair Manager-Medical Affairs-India & South Asia GE Healthcare Context Cancer patients

More information

CATH LAB SYMPOSIUM 2010

CATH LAB SYMPOSIUM 2010 CATH LAB SYMPOSIUM 2010 Low resistance system High Pressure in Capillaries to filter plasma RBF: 1.2-1.3 L/min (25% of C.O.) Low AV difference ( shunt ) Kidney: 14 ml O2/L blood Brain: 62 ml O2/L blood

More information

Contrast Induced Nephropathy

Contrast Induced Nephropathy Contrast Induced Nephropathy O CIAKI refers to an abrupt deterioration in renal function associated with the administration of iodinated contrast media O CIAKI is characterized by an acute (within 48 hours)

More information

Protocol for iv. iodine and gadolinium contrast studies

Protocol for iv. iodine and gadolinium contrast studies Protocol for iv. iodine and gadolinium contrast studies Royal College of Radiologists Standard The individual administering the contrast agent must ensure that the patient understands that it is to be

More information

Prevention of Contrast induced Nephropathy

Prevention of Contrast induced Nephropathy 55 th Annual Scientific Meeting of The Korean Society of Cardiology 11:50 12:10 Message from Nephrologists Dec 03, 2011 Prevention of Contrast induced Nephropathy Soo Wan Kim, MD, PhD Department of Internal

More information

CTA in acute stroke assessment

CTA in acute stroke assessment CTA in acute stroke assessment Assumptions: It is more efficient to cancel an unnecessary CTA than to order a CTA after the fact It is more efficient to make 1 trip to the CT scanner Even if no LVO, CTA

More information

SAFETY IN THE CATH LAB How to Minimise Contrast Toxicity

SAFETY IN THE CATH LAB How to Minimise Contrast Toxicity SAFETY IN THE CATH LAB How to Minimise Contrast Toxicity Dr. Vijay Kunadian MBBS, MD, MRCP Senior Lecturer and Consultant Interventional Cardiologist Institute of Cellular Medicine, Faculty of Medical

More information

A Paradigm Shift in Contrast-Induced Acute Kidney Injury (CI-AKI) Prevention

A Paradigm Shift in Contrast-Induced Acute Kidney Injury (CI-AKI) Prevention CE Mark US: Investigational device. Limited by Federal Law to investigational use only. A Paradigm Shift in Contrast-Induced Acute Kidney Injury (CI-AKI) Prevention 1 ED00092 Rev. A Clinical Problem 2

More information

Doreen P. Foley MS RN ANP-C Doctor of Nursing Practice Program Chamberlain College of Nursing

Doreen P. Foley MS RN ANP-C Doctor of Nursing Practice Program Chamberlain College of Nursing Doreen P. Foley MS RN ANP-C Doctor of Nursing Practice Program Chamberlain College of Nursing This program has been developed solely for the purposes of describing the level of nurse practitioner (NP)

More information

Acute Coronary Syndrome (ACS) Patients with Chronic Kidney Disease being considered for Cardiac Catheterization. PROVINCIAL PROTOCOL March 2015

Acute Coronary Syndrome (ACS) Patients with Chronic Kidney Disease being considered for Cardiac Catheterization. PROVINCIAL PROTOCOL March 2015 Acute Coronary Syndrome (ACS) Patients with Chronic Kidney Disease being considered for Cardiac Catheterization PROVINCIAL PROTOCOL March 2015 Contents Introduction.......................1 Assessing kidney

More information

EVALUATION OF THE ROLE OF NEPHROTOXIC DRUGS IN CONTRAST INDUCED

EVALUATION OF THE ROLE OF NEPHROTOXIC DRUGS IN CONTRAST INDUCED EVALUATION OF THE ROLE OF NEPHROTOXIC DRUGS IN CONTRAST INDUCED NEPHROPATHY (CIN) Dr. SIRISHA.A POST GRADUATE KAMINENI INSTITUTE OF MEDICAL SCIENCES NARKETPALLY, TELANGANA INTRODUCTION Contrast-induced

More information

Patient referral for elective coronary angiography: challenging the current strategy

Patient referral for elective coronary angiography: challenging the current strategy Patient referral for elective coronary angiography: challenging the current strategy M. Santos, A. Ferreira, A. P. Sousa, J. Brito, R. Calé, L. Raposo, P. Gonçalves, R. Teles, M. Almeida, M. Mendes Cardiology

More information

Correspondence should be addressed to Lantam Sonhaye;

Correspondence should be addressed to Lantam Sonhaye; Radiology Research and Practice Volume 2015, Article ID 805786, 4 pages http://dx.doi.org/10.1155/2015/805786 Research Article Intravenous Contrast Medium Administration for Computed Tomography Scan in

More information

2/20/2013. Why use imaging in CV prevention? Update on coronary CTA in 2013 Coronary CTA for 1 0 prevention: pros and cons Are we there yet?

2/20/2013. Why use imaging in CV prevention? Update on coronary CTA in 2013 Coronary CTA for 1 0 prevention: pros and cons Are we there yet? Evolving Role of Coronary CTA in Primary Cardiovascular Disease Prevention: Are We There Yet? Ron Blankstein, M.D., F.A.C.C. Co-Director, Cardiovascular Imaging Training Program Associate Physician, Preventive

More information

SYNTAX III REVOLUTION Trial Press briefing conference. Prof. Patrick W. Serruys MD, PhD Principal Investigator Imperial College of London

SYNTAX III REVOLUTION Trial Press briefing conference. Prof. Patrick W. Serruys MD, PhD Principal Investigator Imperial College of London SYNTAX III REVOLUTION Trial Press briefing conference Prof. Patrick W. Serruys MD, PhD Principal Investigator Imperial College of London Title: Coronary Computed Tomography Angiography for Heart Team Decision-making

More information

Version 4.4. Institutional Outcomes Report 2014Q3. National Outcomes Report Aggregation Date: Jan 12, :59:59 PM

Version 4.4. Institutional Outcomes Report 2014Q3. National Outcomes Report Aggregation Date: Jan 12, :59:59 PM Version 4.4 Institutional Outcomes Report 2014Q3 National Outcomes Report 999997 Aggregation Date: Jan 12, 2015 11:59:59 PM Publish Date: Jan 29, 2015 If User desires to publish or otherwise distribute

More information

The 2016 NASCI Keynote: Trends in Utilization of Cardiac Imaging: The Coronary CTA Conundrum. David C. Levin, M.D.

The 2016 NASCI Keynote: Trends in Utilization of Cardiac Imaging: The Coronary CTA Conundrum. David C. Levin, M.D. The 2016 NASCI Keynote: Trends in Utilization of Cardiac Imaging: The Coronary CTA Conundrum David C. Levin, M.D. October 16, 2016 MPI Utilization Rates/1000[includes PET] total radiologists 2014 total

More information

Low-Dose Computed Tomography Coronary Angiography With Prospective Electrocardiogram Triggering

Low-Dose Computed Tomography Coronary Angiography With Prospective Electrocardiogram Triggering Journal of the American College of Cardiology Vol. 57, No. 3, 2011 2011 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2010.08.634

More information

Novel Risk Markers in ACS (Hyperglycemia, Anemia, GFR)

Novel Risk Markers in ACS (Hyperglycemia, Anemia, GFR) Novel Risk Markers in ACS (Hyperglycemia, Anemia, GFR) Shaul Atar, MD Department of Cardiology Faculty of Medicine of the Galilee Western Galilee Medical Center, Nahariya, Israel TIMI Risk Score Age 65

More information

DONOR CORONARY ANGIOGRAPHY PROTOCOL

DONOR CORONARY ANGIOGRAPHY PROTOCOL Guidance Document DONOR CORONARY ANGIOGRAPHY PROTOCOL ATCA-TSANZ Guidelines 002/2015 Version 1.0, 27 March 2015 1 Table of Contents 1 Purpose 2 Preamble Introduction 4 Donor Heart Allocation protocol 4

More information

Mortality Associated With Nephropathy After Radiographic Contrast Exposure

Mortality Associated With Nephropathy After Radiographic Contrast Exposure ORIGINAL ARTICLE MORTALITY ASSOCIATED WITH NEPHROPATHY AFTER RADIOGRAPHIC CONTRAST EXPOSURE Mortality Associated With Nephropathy After Radiographic Contrast Exposure AARON M. FROM, MD; BRIAN J. BARTHOLMAI,

More information

Clinical Lessons from BMC2-PCI

Clinical Lessons from BMC2-PCI Clinical Lessons from BMC2-PCI The Blue Cross Blue Shield of Michigan Cardiovascular Consortium Hitinder Gurm, M.D. University of Michigan Overview 32 papers since inception 10 papers published this year

More information

Horizon Scanning Technology Summary. Magnetic resonance angiography (MRA) imaging for the detection of coronary artery disease

Horizon Scanning Technology Summary. Magnetic resonance angiography (MRA) imaging for the detection of coronary artery disease Horizon Scanning Technology Summary National Horizon Scanning Centre Magnetic resonance angiography (MRA) imaging for the detection of coronary artery disease April 2007 This technology summary is based

More information

Noninvasive cardiac imaging refers

Noninvasive cardiac imaging refers CARDIOLOGY PATIENT PAGE Introduction to Noninvasive Cardiac Imaging Ron Blankstein, MD Noninvasive cardiac imaging refers to a combination of methods that can be used to obtain images related to the structure

More information

With increased use of contrast media (CM), interest in

With increased use of contrast media (CM), interest in ORIGINAL RESEARCH S. Langner S. Stumpe M. Kirsch M. Petrik N. Hosten No Increased Risk for Contrast-Induced Nephropathy after Multiple CT Perfusion Studies of the Brain with a Nonionic, Dimeric, Iso-Osmolal

More information

Computer Aided Detection and Diagnosis: Cardiac Imaging Applications

Computer Aided Detection and Diagnosis: Cardiac Imaging Applications Computer Aided Detection and Diagnosis: Cardiac Imaging Applications U. Joseph Schoepf, MD, FAHA, FSCBT MR, FSCCT Professor of Radiology, Medicine, and Pediatrics Director of Cardiovascular Imaging Disclosures

More information

A Light in the Dark: Cardiac MRI and Risk Mitigation. J. Ronald Mikolich MD Professor of Internal Medicine Northeast Ohio Medical University (NEOMED)

A Light in the Dark: Cardiac MRI and Risk Mitigation. J. Ronald Mikolich MD Professor of Internal Medicine Northeast Ohio Medical University (NEOMED) A Light in the Dark: Cardiac MRI and Risk Mitigation J. Ronald Mikolich MD Professor of Internal Medicine Northeast Ohio Medical University (NEOMED) Dr. Mikolich has NO financial disclosures relative to

More information

Life After CORAL: What Did CORAL Prove? David Paul Slovut, MD, PhD Co-director TAVR, Dir of Advanced Intervention

Life After CORAL: What Did CORAL Prove? David Paul Slovut, MD, PhD Co-director TAVR, Dir of Advanced Intervention Life After CORAL: What Did CORAL Prove? David Paul Slovut, MD, PhD Co-director TAVR, Dir of Advanced Intervention No Relationships to Disclose The Need for Modern Renal Trials Increased rate of RAS diagnosis

More information

Current and Future Imaging Trends in Risk Stratification for CAD

Current and Future Imaging Trends in Risk Stratification for CAD Current and Future Imaging Trends in Risk Stratification for CAD Brian P. Griffin, MD FACC Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic Disclosures: None Introduction

More information

Kavitha Yaddanapudi Stony brook University New York

Kavitha Yaddanapudi Stony brook University New York Kavitha Yaddanapudi Stony brook University New York 8 million ER visits a year for chest pain 2-10% have Acute coronary syndrome (ACS) Coronary CTA(CCTA) -safe alternative to standard of care (SOC) and

More information

The patient with 30 min chest pain presenting at the ER two hours after onset of symptoms. Professor Christian Mueller

The patient with 30 min chest pain presenting at the ER two hours after onset of symptoms. Professor Christian Mueller The patient with 30 min chest pain presenting at the ER two hours after onset of symptoms Professor Christian Mueller Disclosures Swiss National Science Foundation.... Research support / travel support

More information

Research Article Changes in Renal Function in Elderly Patients Following Intravenous Iodinated Contrast Administration: A Retrospective Study

Research Article Changes in Renal Function in Elderly Patients Following Intravenous Iodinated Contrast Administration: A Retrospective Study Radiology Research and Practice, Article ID 459583, 4 pages http://dx.doi.org/10.1155/2014/459583 Research Article Changes in Renal Function in Elderly Patients Following Intravenous Iodinated Contrast

More information

The PRESERVE trial: does it guide prevention strategies for post angiography acute kidney injury?

The PRESERVE trial: does it guide prevention strategies for post angiography acute kidney injury? Editorial Page 1 of 7 The PRESERVE trial: does it guide prevention strategies for post angiography acute kidney injury? Richard Solomon Larner College of Medicine, University of Vermont, Burlington, VT,

More information

Ischemic Mitral Valve Disease: Repair, Replace or Ignore?

Ischemic Mitral Valve Disease: Repair, Replace or Ignore? Ischemic Mitral Valve Disease: Repair, Replace or Ignore? Fabio B. Jatene Full Professor of Cardiovascular Surgery, Medical School, University of São Paulo, Brazil DISCLOSURE I have no financial relationship

More information

Optimal testing for coronary artery disease in symptomatic and asymptomatic patients

Optimal testing for coronary artery disease in symptomatic and asymptomatic patients Optimal testing for coronary artery disease in symptomatic and asymptomatic patients Alexandre C Ferreira, MD Clinical Chief of Cardiology Jackson Health System Director, Interventional Cardiology Training

More information

The Who, How and When of Advanced Heart Failure Therapies. Disclosures. What is Advanced Heart Failure?

The Who, How and When of Advanced Heart Failure Therapies. Disclosures. What is Advanced Heart Failure? The Who, How and When of Advanced Heart Failure Therapies 9 th Annual Dartmouth Conference on Advances in Heart Failure Therapies Dartmouth-Hitchcock Medical Center Lebanon, NH May 20, 2013 Joseph G. Rogers,

More information

Radial Artery Access Improving Outcomes and Decreasing Costs

Radial Artery Access Improving Outcomes and Decreasing Costs Howard A. Cohen, MD, FACC, FSCAI Director, Division of Cardiac Intervention Co-Director, Cardiac Catheterization Laboratories Lenox Hill Heart & Vascular Institute Institute DISCLOSURE Nothing to disclose

More information

Optimal Imaging Technique Prior to TAVI -Echocardiography-

Optimal Imaging Technique Prior to TAVI -Echocardiography- 2014 KSC meeting Optimal Imaging Technique Prior to TAVI -Echocardiography- Geu-Ru Hong, M.D. Ph D Associate Professor of Medicine Division of Cardiology, Severance Cardiovascular Hospital Yonsei University

More information

Low-dose and High-resolution Cardiac Imaging with Revolution CT

Low-dose and High-resolution Cardiac Imaging with Revolution CT GE Healthcare Case study Low-dose and High-resolution Cardiac Imaging with Revolution CT Prof. Philipp A. Kaufmann, M.D. Ronny R. Buechel, M.D. Fran Mikulicic, M.D. Dominik C. Benz, M.D. University of

More information

N-acetylcysteine in the prevention of contrast agent-induced nephrotoxicity in patients undergoing computed tomography studies

N-acetylcysteine in the prevention of contrast agent-induced nephrotoxicity in patients undergoing computed tomography studies RESEARCH REPORT N-acetylcysteine in the prevention of contrast agent-induced nephrotoxicity in patients undergoing computed tomography studies Hossein Khalili, Simin Dashti-Khavidaki, Hamed Tabifar, Nasrin

More information

Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future

Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future Prof. Juhani Knuuti, MD, FESC Turku, Finland Disclosure: Juhani Knuuti, M.D. Juhani Knuuti, M.D. has financial

More information

Multisclice CT in combination with functional imaging for CAD. Temporal Resolution. Spatial Resolution. Temporal resolution = ½ of the rotation time

Multisclice CT in combination with functional imaging for CAD. Temporal Resolution. Spatial Resolution. Temporal resolution = ½ of the rotation time Multisclice CT in combination with functional imaging for CAD Prof. Juhani Knuuti, MD, FESC Turku University Hospital and University of Turku Turku, Finland MSCT and functional imaging for CAD Practical

More information

Nephrogram type. Days between first and second NCCT

Nephrogram type. Days between first and second NCCT Supplemental Table 1. Characteristics of patients with multiple unenhanced CT scans number Contrastenhanced procedure Pre-CE exam egfr present at first NCCT type Days between first and second NCCT present

More information

Presenter Disclosure Information

Presenter Disclosure Information Presenter Disclosure Information Name: Giora Weisz, MD Within the past 12 months, the presenter or their spouse/partner have had a financial interest/arrangement or affiliation with the organization ion

More information

Fractional Flow Reserve from Coronary CT Angiography (and some neat CT images)

Fractional Flow Reserve from Coronary CT Angiography (and some neat CT images) Fractional Flow Reserve from Coronary CT Angiography (and some neat CT images) Victor Cheng, M.D. Director, Cardiovascular CT Oklahoma Heart Institute 1 Disclosures Tornadoes scare me 2 Treating CAD Fixing

More information

Intravascular Ultrasound in the Treatment of Complex Aortic Pathologies. Naixin Kang, M.D. Vascular Surgery Fellow April 26 th, 2018

Intravascular Ultrasound in the Treatment of Complex Aortic Pathologies. Naixin Kang, M.D. Vascular Surgery Fellow April 26 th, 2018 Intravascular Ultrasound in the Treatment of Complex Aortic Pathologies Naixin Kang, M.D. Vascular Surgery Fellow April 26 th, 2018 DISCLOSURES Nothing To Disclose 2 ENDOVASCULAR AORTIC INTERVENTION Improved

More information

Acute Coronary Syndrome. Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine

Acute Coronary Syndrome. Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine Acute Coronary Syndrome Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine Topics Timing is everything So many drugs to choose from What s a MINOCA? 2 Acute

More information

New Stable Chest Pain Guidance in the UK NICE to have, difficult to implement

New Stable Chest Pain Guidance in the UK NICE to have, difficult to implement New Stable Chest Pain Guidance in the UK NICE to have, difficult to implement Dr Tim Fairbairn MBChB, MRCP, PhD Consultant Imaging Cardiologist Liverpool Heart and Chest Hospital, United Kingdom 2010 Risk

More information

Follow-up of patients with contrast-induced nephropathy

Follow-up of patients with contrast-induced nephropathy http://www.kidney-international.org & 2006 International Society of Nephrology Follow-up of patients with contrast-induced nephropathy R Solomon 1 and B Barrett 2 1 Fletcher Allen Health Care, University

More information

CT FFR: Are you ready to totally change the way you diagnose Coronary Artery Disease?

CT FFR: Are you ready to totally change the way you diagnose Coronary Artery Disease? CT FFR: Are you ready to totally change the way you diagnose Coronary Artery Disease? Madan Mohan MD MRCP FACC CQO, Division of Cardiovascular Medicine University Hospitals Case Medical Center Assistant

More information

CT or PET/CT for coronary artery disease

CT or PET/CT for coronary artery disease CT or PET/CT for coronary artery disease Rotterdam 2012 Juhani Knuuti, MD, PhD, FESC Turku PET Centre University of Turku Turku, Finland Juhani.knuuti@utu.fi Turku PET Centre University of Turku Åbo Akademi

More information

Mædica - a Journal of Clinical Medicine

Mædica - a Journal of Clinical Medicine MAEDICA a Journal of Clinical Medicine 2013; 8(2): 103-107 Mædica - a Journal of Clinical Medicine ORIGINAL PAPERS Early Clinical Outcomes of Primary Percutaneous Coronary Intervention in Bharatpur, Nepal

More information

Evidence for Everyone: Expanding the Reach of Health Technology Assessment 2016 CADTH Symposium, April 10-12, Shaw Centre, Ottawa

Evidence for Everyone: Expanding the Reach of Health Technology Assessment 2016 CADTH Symposium, April 10-12, Shaw Centre, Ottawa Dr. Ross Davies President Dr. Benjamin Chow Vice-President Dr. Jonathan Leipsic Secretary/Treasurer Office 222 Queen Street Suite 1403 Ottawa, ON K1P 5V9 www.ccs.ca/ nuclear_ct@ccs.ca Evidence for Everyone:

More information

Physician Self-referral and Health Care Utilization. Rita F. Redberg, MD, MSc Professor of Medicine UCSF Medical Center

Physician Self-referral and Health Care Utilization. Rita F. Redberg, MD, MSc Professor of Medicine UCSF Medical Center Physician Self-referral and Health Care Utilization Rita F. Redberg, MD, MSc Professor of Medicine UCSF Medical Center Physician self-referral why should we care? Extent of occurrences Impact of physician

More information

Multimodality Imaging in Spontaneous Coronary Artery Dissection in the Peripartum Period

Multimodality Imaging in Spontaneous Coronary Artery Dissection in the Peripartum Period Multimodality Imaging in Spontaneous Coronary Artery Dissection in the Peripartum Period Marysia Tweet, MD NASCI Annual Meeting October 18 th, 2016 2016 MFMER slide-1 DISCLOSURE No relevant financial relationship(s)

More information

TAVR y Enfermedad Coronaria. Mauricio G. Cohen, MD, FACC, FSCAI Director, Cardiac Catheterization Lab Associate Professor of Medicine

TAVR y Enfermedad Coronaria. Mauricio G. Cohen, MD, FACC, FSCAI Director, Cardiac Catheterization Lab Associate Professor of Medicine TAVR y Enfermedad Coronaria Mauricio G. Cohen, MD, FACC, FSCAI Director, Cardiac Catheterization Lab Associate Professor of Medicine CAD and AS Similar Pathological Processes CAD in TAVR Patients (n=390)

More information

Out-of-hospital Cardiac Arrest. Franz R. Eberli MD, FESC, FAHA Cardiology Triemli Hospital Zurich, Switzerland

Out-of-hospital Cardiac Arrest. Franz R. Eberli MD, FESC, FAHA Cardiology Triemli Hospital Zurich, Switzerland Out-of-hospital Cardiac Arrest Franz R. Eberli MD, FESC, FAHA Cardiology Triemli Hospital Zurich, Switzerland Conflict of Interest I have no conflict of interest to disclose regarding this presentation.

More information

Cardiothoracic Department October 9, Deborah Winters, RN BSN Clinical Excellence

Cardiothoracic Department October 9, Deborah Winters, RN BSN Clinical Excellence Cardiothoracic Department October 9, 2013 Deborah Winters, RN BSN Clinical Excellence Quarterly Executive Summary CathPCI Registry PCI Performance Measures PCI Process/Outcome Metrics Diagnostic Cath Process/Outcome

More information

Detection Of Functional Significance of Coronary Stenoses Using Dynamic. Values Of Myocardial Blood Flow And Coronary Flow Reserve

Detection Of Functional Significance of Coronary Stenoses Using Dynamic. Values Of Myocardial Blood Flow And Coronary Flow Reserve The 2nd International Symposium on Physics, Engineering and Technologies for Biomedicine Volume 2018 Conference Paper Detection Of Functional Significance of Coronary Stenoses Using Dynamic 13 N-Ammonia

More information

Culprit PCI vs MultiVessel PCI for Acute Myocardial Infarction

Culprit PCI vs MultiVessel PCI for Acute Myocardial Infarction Culprit PCI vs MultiVessel PCI for Acute Myocardial Infarction Dipti Itchhaporia, MD, FACC, FESC Trustee, American College of Cardiology Director of Disease Management, Hoag Hospital Robert and Georgia

More information

Combining Coronary Artery Calcium Scanning with SPECT/PET Myocardial Perfusion Imaging

Combining Coronary Artery Calcium Scanning with SPECT/PET Myocardial Perfusion Imaging Combining Coronary Artery Calcium Scanning with SPECT/PET Myocardial Perfusion Imaging Daniel S. Berman, MD Director, Cardiac Imaging Cedars-Sinai Heart Institute Professor of Medicine and Imaging Cedars-Sinai

More information

New Technologies for Cardiac CT. Geoffrey D. Rubin, MD, MBA, FACR, FNASCI Duke University

New Technologies for Cardiac CT. Geoffrey D. Rubin, MD, MBA, FACR, FNASCI Duke University 1996 New Technologies for Cardiac CT Geoffrey D. Rubin, MD, MBA, FACR, FNASCI Duke University New Technology The Long View Levels of Efficacy Endpoint Examples 1: Technical Imaging resolution 2: Diagnostic

More information

Acute Kidney Injury in Trauma. David Lee Skinner MBChB FCS(SA) Trauma Unit Inkosi Albert Luthuli Central Hospital KwaZulu Natal South Africa

Acute Kidney Injury in Trauma. David Lee Skinner MBChB FCS(SA) Trauma Unit Inkosi Albert Luthuli Central Hospital KwaZulu Natal South Africa Acute Kidney Injury in Trauma David Lee Skinner MBChB FCS(SA) Trauma Unit Inkosi Albert Luthuli Central Hospital KwaZulu Natal South Africa Acute Kidney Injury Acute Renal Failure RIFLE & AKIN RIFLE criteria

More information

Pro-enkephalin and Renal Disease. Alan H. Wu, Ph.D. University of California, San Francisco 12 th Annual UCSD Biomarkers of Cardiac Disease

Pro-enkephalin and Renal Disease. Alan H. Wu, Ph.D. University of California, San Francisco 12 th Annual UCSD Biomarkers of Cardiac Disease Pro-enkephalin and Renal Disease Alan H. Wu, Ph.D. University of California, San Francisco 12 th Annual UCSD Biomarkers of Cardiac Disease The presenter has received relevant grants and /or consulting

More information

Stress only Perfusion Imaging

Stress only Perfusion Imaging European Society of Cardiology Annual meeting, 2010, Stockholm, Sweden Stress only Perfusion Imaging Oliver Gaemperli, MD Cardiovascular Center, University Hospital Zurich, Switzerland Male patient, 48

More information

FFR Incorporating & Expanding it s use in Clinical Practice

FFR Incorporating & Expanding it s use in Clinical Practice FFR Incorporating & Expanding it s use in Clinical Practice Suleiman Kharabsheh, MD Consultant Invasive Cardiology Assistant professor, Alfaisal Univ. KFHI - KFSHRC Concept of FFR Maximum flow down a vessel

More information

The Emerging Role of Cardiac CT in Cardiovascular Imaging. Anthony Gemignani, MD Vermont Cardiac Network April 28, 2016

The Emerging Role of Cardiac CT in Cardiovascular Imaging. Anthony Gemignani, MD Vermont Cardiac Network April 28, 2016 The Emerging Role of Cardiac CT in Cardiovascular Imaging Anthony Gemignani, MD Vermont Cardiac Network April 28, 2016 Conflict Disclosures I have no significant financial relationship with any companies

More information

Overview. Health and economic burden of coronary artery disease (CAD) Pitfalls in care of patients suspected of having CAD

Overview. Health and economic burden of coronary artery disease (CAD) Pitfalls in care of patients suspected of having CAD Quality Challenges and Pitfalls in the Evaluation of Patients with Suspected Heart Disease Joseph A. Ladapo, MD, PhD Assistant Professor of Medicine Department of Population Health NYU School of Medicine

More information

DECLARATION OF CONFLICT OF INTEREST. Research grants: Sanofi-Aventis

DECLARATION OF CONFLICT OF INTEREST. Research grants: Sanofi-Aventis DECLARATION OF CONFLICT OF INTEREST Research grants: Sanofi-Aventis Invasive management after cardiac arrest Nikolaos I Nikolaou FESC, FERC Athens, Greece Survival (%) Survival from Out of Hospital Cardiac

More information

of developing contrast -induced

of developing contrast -induced Original Article Singapore Med 1 2009, 50 (3) : 250 Diabetic patients with normal baseline renal function are at increased risk of developing contrast -induced nephropathy post-percutaneous coronary intervention

More information

Fractional Flow Reserve: Basics, FAME 1, FAME 2. William F. Fearon, MD Associate Professor Stanford University Medical Center

Fractional Flow Reserve: Basics, FAME 1, FAME 2. William F. Fearon, MD Associate Professor Stanford University Medical Center Fractional Flow Reserve: Basics, FAME 1, FAME 2 William F. Fearon, MD Associate Professor Stanford University Medical Center Conflict of Interest Advisory Board for HeartFlow Research grant from St. Jude

More information

High Risk PCI for Heart Failure

High Risk PCI for Heart Failure High Risk PCI for Heart Failure Ray Matthews MD Professor of Clinical Medicine Chief, Division of Cardiovascular Medicine University of Southern California Los Angeles, California Disclosures Abiomed Research

More information

Computed Tomography of the Coronary Arteries

Computed Tomography of the Coronary Arteries Cardiology Update DAVOS 2011 Computed Tomography of the Coronary Arteries Anders Persson M.D., Ph.D Director, Assoc. Professor Center for Medical Image Science and Visualization Linköping University SWEDEN

More information

Evaluating the Efficacy of Single Daily Dose of 1200mg of N-Acetyl-Cysteine in Preventing Contrast Agent-Associated Nephrotoxicity

Evaluating the Efficacy of Single Daily Dose of 1200mg of N-Acetyl-Cysteine in Preventing Contrast Agent-Associated Nephrotoxicity ISPUB.COM The Internet Journal of Internal Medicine Volume 6 Number 1 Evaluating the Efficacy of Single Daily Dose of 1200mg of N-Acetyl-Cysteine in Preventing Contrast Agent-Associated Nephrotoxicity

More information

Coronary Artery Manifestations of Fibromuscular Dysplasia: Infrequent and Easily Missed

Coronary Artery Manifestations of Fibromuscular Dysplasia: Infrequent and Easily Missed Coronary Artery Manifestations of Fibromuscular Dysplasia: Infrequent and Easily Missed Jeffrey W Olin, D.O., F.A.C.C., F.A.H.A. Professor of Medicine (Cardiology) Director of Vascular Medicine & Vascular

More information

Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines

Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines Enrico Ferrari, MD Cardiac Surgery Unit Cardiocentro Ticino Foundation Lugano, Switzerland Conflict of Interests No conflict

More information

Renal artery stenosis

Renal artery stenosis Renal artery stenosis Dr. Alexander Woywodt Consultant Renal Physician, Royal Preston Hospital Preston, 31.10.2007 Menu anatomy of the renal arteries diseases of the large renal arteries atherosclerotic

More information

Renal Artery Stenting

Renal Artery Stenting Renal Artery Stenting J.P. Reilly, MD, FSCAI Ochsner Medical Center Speaker s bureau: Astra Zeneca and Lilly/Diachi Sankyo Prevalence of RAS is high in cath population. Renal artery intervention can help

More information

Screening and early recognition of CKD. John Ngigi (FISN) Kidney specialist

Screening and early recognition of CKD. John Ngigi (FISN) Kidney specialist Screening and early recognition of CKD John Ngigi (FISN) Kidney specialist screening Why? Who? When? How? Primary diagnosis for patients who start dialysis Other 10% Glomerulonephritis 13% No. of dialysis

More information

New Jersey Cardiac Catheterization Data Registry, Version 2.0 (Please report data only for patients 16 years or older.)

New Jersey Cardiac Catheterization Data Registry, Version 2.0 (Please report data only for patients 16 years or older.) A. ADMINISTRATIVE New Jersey Cardiac Catheterization Data Registry, Version 2.0 (Please report data only for patients 16 years or older.) 1. Facility Code: 2. Facility Name: 3. Procedure Type (Choose only

More information

Pearls in Acute Heart Failure Management

Pearls in Acute Heart Failure Management Pearls in Acute Heart Failure Management Best Practices Juan M. Aranda Jr., M.D. Professor of Medicine Medical Director of Heart Failure/ Transplant Program University of Florida College of Medicine Disclosures:

More information

Cardiovascular Disease in CKD. Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center

Cardiovascular Disease in CKD. Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center Cardiovascular Disease in CKD Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center Objectives Describe prevalence for cardiovascular disease in CKD

More information

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More?

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More? CIPG 2013 Transcatheter Aortic Valve Replacement- When Is Less, More? James D. Rossen, M.D. Professor of Medicine and Neurosurgery Director, Cardiac Catheterization Laboratory and Interventional Cardiology

More information

Which Test When? Avoid the Stress of Stress Testing. Marc Newell, MD, FACC, FSCCT Minneapolis Heart Institute

Which Test When? Avoid the Stress of Stress Testing. Marc Newell, MD, FACC, FSCCT Minneapolis Heart Institute Which Test When? Avoid the Stress of Stress Testing Marc Newell, MD, FACC, FSCCT Minneapolis Heart Institute Outline Understand the importance of coronary artery disease assessment Understand the basics

More information

Cardiotoxicity: The View of the Cardiologist

Cardiotoxicity: The View of the Cardiologist Cardiotoxicity: The View of the Cardiologist Dr. Yael Peled, Cardio-Oncology Interactions: 1.Cardiotoxicity following chemotherapy 2. Co existence of cancer and CVD Aging & common risk factors cardiac

More information

WORSENING OF RENAL FUNCTION AFTER RAS INHIBITION IN DECOMPENSATED HEART FAILURE: CLINICAL IMPLICATIONS

WORSENING OF RENAL FUNCTION AFTER RAS INHIBITION IN DECOMPENSATED HEART FAILURE: CLINICAL IMPLICATIONS WORSENING OF RENAL FUNCTION AFTER RAS INHIBITION IN DECOMPENSATED HEART FAILURE: CLINICAL IMPLICATIONS George Bakris, MD, FASH, FAHA, FASN Professor of Medicine Director, Comprehensive Hypertension Center

More information

Competency Portfolio for the Diploma in Adult Interventional Cardiology

Competency Portfolio for the Diploma in Adult Interventional Cardiology Competency Portfolio for the Diploma in Adult Interventional Cardiology For Candidates to Complete 2013 VERSION 2.1 This portfolio applies to those who begin training on or after July 1 st, 2013. DEFINITION

More information

The Latest on CT Fractional Flow Reserve. Dimitris Mitsouras, Ph.D.

The Latest on CT Fractional Flow Reserve. Dimitris Mitsouras, Ph.D. The Latest on CT Fractional Flow Reserve Dimitris Mitsouras, Ph.D. Assistant Professor of Radiology Harvard Medical School Director, Applied Imaging Science Lab Brigham and Women s Hospital Disclosures

More information

Original Article INTRODUCTION

Original Article INTRODUCTION Original Article Defining the at risk patients for contrast induced nephropathy after coronary angiography; 24-h urine creatinine versus Cockcroft-Gault equation or serum creatinine level Ahmadreza Assareh,

More information

Complicanze durante TAVI. Brambilla Nedy IRCCS Policlinico San Donato

Complicanze durante TAVI. Brambilla Nedy IRCCS Policlinico San Donato Complicanze durante TAVI Brambilla Nedy IRCCS Policlinico San Donato 0 2 4 6 9 11 14 16 22 26 31 33 37 43 52 61 69 78 87 93 106 113 121 151 171 186 201 225 267 283 294 311 349 502 515 709 1007 Number of

More information

ΔΙΑΒΗΤΗΣ ΚΑΙ ΣΙΩΠΗΡΗ ΙΣΧΑΙΜΙΑ. Δρ. ΛΑΦΑΡΑΣ ΧΡΗΣΤΟΣ

ΔΙΑΒΗΤΗΣ ΚΑΙ ΣΙΩΠΗΡΗ ΙΣΧΑΙΜΙΑ. Δρ. ΛΑΦΑΡΑΣ ΧΡΗΣΤΟΣ ΔΙΑΒΗΤΗΣ ΚΑΙ ΣΙΩΠΗΡΗ ΙΣΧΑΙΜΙΑ Δρ. ΛΑΦΑΡΑΣ ΧΡΗΣΤΟΣ Διευθυντής Καρδιολογικού Τμήματος, Α.Ν.Θ Θεαγένειο, Θεσσαλονίκη ΔΕΚΕΜΒΡΙΟΣ 2015 Introduction The incidence of diabetes mellitus is increasing globally.

More information

The Incidence of Contrast Induced Nephropathy in Trauma Patients.

The Incidence of Contrast Induced Nephropathy in Trauma Patients. The Incidence of Contrast Induced Nephropathy in Trauma Patients. Item Type Thesis Authors Cordeiro, Samuel Publisher The University of Arizona. Rights Copyright is held by the author. Digital access to

More information

Purpose. Methods and Materials

Purpose. Methods and Materials Comparison of iterative and filtered back-projection image reconstruction techniques: evaluation of heavily calcified vessels with coronary CT angiography Poster No.: C-1644 Congress: ECR 2011 Type: Scientific

More information

Metformin appears to be a useful therapeutic option for physicians wishing to use drug therapy to control blood glucose levels. 3

Metformin appears to be a useful therapeutic option for physicians wishing to use drug therapy to control blood glucose levels. 3 VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Type 2 diabetes mellitus Rates of diabetes are increasing worldwide. The International Diabetes Federation predicts that the number

More information

Indication, Timing, Assessment and Update on TAVI

Indication, Timing, Assessment and Update on TAVI Indication, Timing, Assessment and Update on TAVI Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Starr- Edwards Mechanical

More information

9/28/2011 CARDIAC CATHETERIZATION CODING DISCLAIMER AGENDA CATRENA SMITH, CCS, CCS-P, CPC, PCS. 1. Cardiac Catheterization s defined

9/28/2011 CARDIAC CATHETERIZATION CODING DISCLAIMER AGENDA CATRENA SMITH, CCS, CCS-P, CPC, PCS. 1. Cardiac Catheterization s defined CARDIAC CATHETERIZATION CODING CATRENA SMITH, CCS, CCS-P, CPC, PCS PRESIDENT, ACCESS QUALITY CODING & CONSULTING, LLC 1 DISCLAIMER This material is provided to assist in education for coders. Every attempt

More information